Transperitoneal robot-assisted partial nephrectomy

A comparison of posterior and anterior renal masses

Kelly T. Harris, Mark W. Ball, Michael Gorin, Kevin M. Curtiss, Phillip Martin Pierorazio, Mohamad E Allaf

Research output: Contribution to journalArticle

Abstract

Background and Purpose: Robot-assisted partial nephrectomy (RAPN) for posterior renal masses necessitates access to the posterior surface of the kidney either via a transperitoneal (TP) or retroperitoneal (RP) approach. While advocates of an RP approach claim reduced morbidity for posterior tumors, it is a less familiar approach to many urologists. In our institution, a TP approach is used for all patients undergoing RAPN. We compared demographics and perioperative outcomes of TP RAPN for posterior and anterior/lateral renal masses. Methods: Our institutional renal mass database was queried for patients with available preoperative imaging who underwent TP RAPN from 2007 to 2013. Posterior masses were accessed by opening the Gerota fascia and rotating the kidney anteromedially. Demographic and perioperative outcomes were compared for patients with posterior masses and anterior/lateral masses. Results: Overall, 260 TP RAPN were identified. Of these, 92 were for posterior tumors and 168 were for anterior and lateral tumors. Renal-cell carcinoma (RCC) was found in 77.3% of cases. Patient demographic and tumor characteristics were similar between groups. Among operative characteristics, warm ischemia time (17 vs 16.5, min P=0.70), operative time (160 vs 159 min, P=0.82), estimated blood loss (100 vs 100 mL, P=0.44), RCC positive surgical margins (1.4% vs 1.5%), and postoperative complications (19.6% vs 16.1%, P=1.0) were similar for posterior and anterior/lateral tumors, respectively. Conclusions: TP RAPN is a safe, effective treatment option for patients with posterior renal masses with no additional morbidity compared with anterior/lateral renal masses. RP PN remains an alternative treatment option.

Original languageEnglish (US)
Pages (from-to)655-659
Number of pages5
JournalJournal of Endourology
Volume28
Issue number6
DOIs
StatePublished - Jun 1 2014

Fingerprint

Nephrectomy
Kidney
Demography
Neoplasms
Renal Cell Carcinoma
Morbidity
Warm Ischemia
Fascia
Operative Time
Databases
Therapeutics

ASJC Scopus subject areas

  • Urology

Cite this

Transperitoneal robot-assisted partial nephrectomy : A comparison of posterior and anterior renal masses. / Harris, Kelly T.; Ball, Mark W.; Gorin, Michael; Curtiss, Kevin M.; Pierorazio, Phillip Martin; Allaf, Mohamad E.

In: Journal of Endourology, Vol. 28, No. 6, 01.06.2014, p. 655-659.

Research output: Contribution to journalArticle

@article{49dda46047394357b890a7be4db1ca98,
title = "Transperitoneal robot-assisted partial nephrectomy: A comparison of posterior and anterior renal masses",
abstract = "Background and Purpose: Robot-assisted partial nephrectomy (RAPN) for posterior renal masses necessitates access to the posterior surface of the kidney either via a transperitoneal (TP) or retroperitoneal (RP) approach. While advocates of an RP approach claim reduced morbidity for posterior tumors, it is a less familiar approach to many urologists. In our institution, a TP approach is used for all patients undergoing RAPN. We compared demographics and perioperative outcomes of TP RAPN for posterior and anterior/lateral renal masses. Methods: Our institutional renal mass database was queried for patients with available preoperative imaging who underwent TP RAPN from 2007 to 2013. Posterior masses were accessed by opening the Gerota fascia and rotating the kidney anteromedially. Demographic and perioperative outcomes were compared for patients with posterior masses and anterior/lateral masses. Results: Overall, 260 TP RAPN were identified. Of these, 92 were for posterior tumors and 168 were for anterior and lateral tumors. Renal-cell carcinoma (RCC) was found in 77.3{\%} of cases. Patient demographic and tumor characteristics were similar between groups. Among operative characteristics, warm ischemia time (17 vs 16.5, min P=0.70), operative time (160 vs 159 min, P=0.82), estimated blood loss (100 vs 100 mL, P=0.44), RCC positive surgical margins (1.4{\%} vs 1.5{\%}), and postoperative complications (19.6{\%} vs 16.1{\%}, P=1.0) were similar for posterior and anterior/lateral tumors, respectively. Conclusions: TP RAPN is a safe, effective treatment option for patients with posterior renal masses with no additional morbidity compared with anterior/lateral renal masses. RP PN remains an alternative treatment option.",
author = "Harris, {Kelly T.} and Ball, {Mark W.} and Michael Gorin and Curtiss, {Kevin M.} and Pierorazio, {Phillip Martin} and Allaf, {Mohamad E}",
year = "2014",
month = "6",
day = "1",
doi = "10.1089/end.2013.0608",
language = "English (US)",
volume = "28",
pages = "655--659",
journal = "Journal of Endourology",
issn = "0892-7790",
publisher = "Mary Ann Liebert Inc.",
number = "6",

}

TY - JOUR

T1 - Transperitoneal robot-assisted partial nephrectomy

T2 - A comparison of posterior and anterior renal masses

AU - Harris, Kelly T.

AU - Ball, Mark W.

AU - Gorin, Michael

AU - Curtiss, Kevin M.

AU - Pierorazio, Phillip Martin

AU - Allaf, Mohamad E

PY - 2014/6/1

Y1 - 2014/6/1

N2 - Background and Purpose: Robot-assisted partial nephrectomy (RAPN) for posterior renal masses necessitates access to the posterior surface of the kidney either via a transperitoneal (TP) or retroperitoneal (RP) approach. While advocates of an RP approach claim reduced morbidity for posterior tumors, it is a less familiar approach to many urologists. In our institution, a TP approach is used for all patients undergoing RAPN. We compared demographics and perioperative outcomes of TP RAPN for posterior and anterior/lateral renal masses. Methods: Our institutional renal mass database was queried for patients with available preoperative imaging who underwent TP RAPN from 2007 to 2013. Posterior masses were accessed by opening the Gerota fascia and rotating the kidney anteromedially. Demographic and perioperative outcomes were compared for patients with posterior masses and anterior/lateral masses. Results: Overall, 260 TP RAPN were identified. Of these, 92 were for posterior tumors and 168 were for anterior and lateral tumors. Renal-cell carcinoma (RCC) was found in 77.3% of cases. Patient demographic and tumor characteristics were similar between groups. Among operative characteristics, warm ischemia time (17 vs 16.5, min P=0.70), operative time (160 vs 159 min, P=0.82), estimated blood loss (100 vs 100 mL, P=0.44), RCC positive surgical margins (1.4% vs 1.5%), and postoperative complications (19.6% vs 16.1%, P=1.0) were similar for posterior and anterior/lateral tumors, respectively. Conclusions: TP RAPN is a safe, effective treatment option for patients with posterior renal masses with no additional morbidity compared with anterior/lateral renal masses. RP PN remains an alternative treatment option.

AB - Background and Purpose: Robot-assisted partial nephrectomy (RAPN) for posterior renal masses necessitates access to the posterior surface of the kidney either via a transperitoneal (TP) or retroperitoneal (RP) approach. While advocates of an RP approach claim reduced morbidity for posterior tumors, it is a less familiar approach to many urologists. In our institution, a TP approach is used for all patients undergoing RAPN. We compared demographics and perioperative outcomes of TP RAPN for posterior and anterior/lateral renal masses. Methods: Our institutional renal mass database was queried for patients with available preoperative imaging who underwent TP RAPN from 2007 to 2013. Posterior masses were accessed by opening the Gerota fascia and rotating the kidney anteromedially. Demographic and perioperative outcomes were compared for patients with posterior masses and anterior/lateral masses. Results: Overall, 260 TP RAPN were identified. Of these, 92 were for posterior tumors and 168 were for anterior and lateral tumors. Renal-cell carcinoma (RCC) was found in 77.3% of cases. Patient demographic and tumor characteristics were similar between groups. Among operative characteristics, warm ischemia time (17 vs 16.5, min P=0.70), operative time (160 vs 159 min, P=0.82), estimated blood loss (100 vs 100 mL, P=0.44), RCC positive surgical margins (1.4% vs 1.5%), and postoperative complications (19.6% vs 16.1%, P=1.0) were similar for posterior and anterior/lateral tumors, respectively. Conclusions: TP RAPN is a safe, effective treatment option for patients with posterior renal masses with no additional morbidity compared with anterior/lateral renal masses. RP PN remains an alternative treatment option.

UR - http://www.scopus.com/inward/record.url?scp=84901979722&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84901979722&partnerID=8YFLogxK

U2 - 10.1089/end.2013.0608

DO - 10.1089/end.2013.0608

M3 - Article

VL - 28

SP - 655

EP - 659

JO - Journal of Endourology

JF - Journal of Endourology

SN - 0892-7790

IS - 6

ER -